Safety Information
| Description | Publish Date | LINKS |
|---|---|---|
| Salbutamol pMDI, Advisory Letter | 15/10/2025 |  |
| Cabotegravir Patient appointment reminder card | 01/08/2024 | |
| Cabotegravir Patient educational brochure | 01/08/2024 | |
| Cabotegravir Provider checklist | 01/08/2024 | |
| Cabotegravir Provider educational brochure | 01/08/2024 | |
| Important safety information on Dolutegravir in Ivory Coast |
10/10/2018 |
|
| Important safety information on Non-steroidal anti-inflammatory drugs (NSAlDs) in Ivory Coast | 11/06/2021 | |
| Important safety information on Paroxetine in Ivory Coast (Safety Notification_EMA communication issued relating to Paroxetine label update) | 27-10-2023 |  |
| Important safety information on Topical Corticosteroids containing products in Ivory Coast | 15-11-2023 | |
Important safety information on Paroxetine containing products - Modifications of the information of medicines authorized by national procedure that contain Paroxetine |
28/12/2023 |
|
